264 related articles for article (PubMed ID: 23782650)
1. Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.
Balder R; Shaffer TL; Lafontaine ER
BMC Microbiol; 2013 Jun; 13():140. PubMed ID: 23782650
[TBL] [Abstract][Full Text] [Related]
2. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
[TBL] [Abstract][Full Text] [Related]
3. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
[TBL] [Abstract][Full Text] [Related]
4. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
[TBL] [Abstract][Full Text] [Related]
5. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE
Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
Bootsma HJ; van Dijk H; Verhoef J; Fleer A; Mooi FR
Antimicrob Agents Chemother; 1996 Apr; 40(4):966-72. PubMed ID: 8849261
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and impact of macrolide antibiotics on Moraxella catarrhalis in the upper and lower airways of children with chronic endobronchial suppuration.
Hare KM; Seib KL; Chang AB; Harris TM; Spargo JC; Smith-Vaughan HC
J Med Microbiol; 2019 Aug; 68(8):1140-1147. PubMed ID: 31274402
[TBL] [Abstract][Full Text] [Related]
8. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China.
Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K
BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595
[TBL] [Abstract][Full Text] [Related]
9. Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.
Jones MM; Johnson A; Koszelak-Rosenblum M; Kirkham C; Brauer AL; Malkowski MG; Murphy TF
Infect Immun; 2014 Nov; 82(11):4758-66. PubMed ID: 25156736
[TBL] [Abstract][Full Text] [Related]
10. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
Köseoglu O; Ergin A; Hascelik G
Scand J Infect Dis; 2004; 36(6-7):431-4. PubMed ID: 15307563
[TBL] [Abstract][Full Text] [Related]
12. Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
Schmitz FJ; Beeck A; Perdikouli M; Boos M; Mayer S; Scheuring S; Köhrer K; Verhoef J; Fluit AC
J Clin Microbiol; 2002 Apr; 40(4):1546-8. PubMed ID: 11923393
[TBL] [Abstract][Full Text] [Related]
13. Natural insertion of the bro-1 β-lactamase gene into the gatCAB operon affects Moraxella catarrhalis aspartyl-tRNA(Asn) amidotransferase activity.
Akochy PM; Lapointe J; Roy PH
Microbiology (Reading); 2012 Sep; 158(Pt 9):2363-2371. PubMed ID: 22745266
[TBL] [Abstract][Full Text] [Related]
14. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
McGregor K; Chang BJ; Mee BJ; Riley TV
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Low DE; Hoban DJ;
Antimicrob Agents Chemother; 2003 Jun; 47(6):1875-81. PubMed ID: 12760861
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
18. Moraxella catarrhalis, a human respiratory tract pathogen.
Murphy TF; Parameswaran GI
Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
[TBL] [Abstract][Full Text] [Related]
19. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
20. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains.
Kadry AA; Fouda SI; Elkhizzi NA; Shibl AM
Int J Antimicrob Agents; 2003 Nov; 22(5):532-6. PubMed ID: 14602374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
